Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-535-4 | CAS number: 84-51-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 02 March 2016 to 25 May 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- Some of the animals in the main study had body weights that marginally exceeded the upper range quoted in the General Study Plan (200g). However, the animals were within the age range quoted and individual dose group weight variation did not exceed 20% of the mean weight. The animals were therefore considered acceptable for use in the study This minor deviation to the GSP was considered not to have affected the purpose or integrity
of the Study. - Deviations:
- yes
- Remarks:
- This minor deviation to the GSP was considered not to have affected the purpose or integrity of the Study.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.12 (Mutagenicity - In Vivo Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- Some of the animals in the main study had body weights that marginally exceeded the upper range quoted in the General Study Plan (200g). However, the animals were within the age range quoted and individual dose group weight variation did not exceed 20% of the mean weight. The animals were therefore considered acceptable for use in the study.
- Deviations:
- yes
- Remarks:
- This minor deviation to the GSP was considered not to have affected the purpose or integrity of the Study.
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5395 (In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay)
- Version / remarks:
- Some of the animals in the main study had body weights that marginally exceeded the upper range quoted in the General Study Plan (200g). However, the animals were within the age range quoted and individual dose group weight variation did not exceed 20% of the mean weight. The animals were therefore considered acceptable for use in the study.
- Deviations:
- yes
- Remarks:
- This minor deviation to the GSP was considered not to have affected the purpose or integrity of the Study.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- endogenous gene animal assay
Test material
- Reference substance name:
- 2-ethylanthraquinone
- EC Number:
- 201-535-4
- EC Name:
- 2-ethylanthraquinone
- Cas Number:
- 84-51-5
- Molecular formula:
- C16H12O2
- IUPAC Name:
- 2-ethyl-9,10-anthraquinone
- Details on test material:
- - Name of test material (as cited in study report): 2-ETHYLANTHRAQUINONE
- Physical state: yellow solid flakes
- Analytical purity: 98.83%
- Impurities (identity and concentrations): not reported
- Purity test date: not reported
- Lot/batch No.: 110929
- Expiration date of the lot/batch: 31 December 2012
- Stability under test conditions: not reported
- Storage condition of test material: room temperature in the dark
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: approximately 7 to 12 weeks old
- Weight at study initiation: 182.6 to 214.4 g
- Assigned to test groups randomly: yes
- Housing: solid-floor polypropylene cages with wood-flake bedding
- Diet (e.g. ad libitum): Free access to mains food was allowed throughout the study
- Water (e.g. ad libitum): Free access to mains drinking water was allowed throughout the study
- Acclimation period: minimum acclimatisation period of five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 to 25ºC
- Humidity (%): 30 to 70%
- Air changes (per hr): fifteen changes per hour
- Photoperiod (hrs dark / hrs light): twelve hours light and twelve hours darkness
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- arachis oil
- Details on exposure:
- Groups, each of five rats, were dosed twice at time 0 and 24 hours via the oral route with the test item at 400, 200 or 100 mg/kg.
Two further groups of rats were included in the study; one group (five rats) was dosed via the oral route with the vehicle alone (arachis oil) and a second group (five rats) was dosed orally with cyclophosphamide. - Duration of treatment / exposure:
- 24 hours
- Frequency of treatment:
- 0 and 24 hours
- Post exposure period:
- 48 hours
Doses / concentrationsopen allclose all
- Dose / conc.:
- 400 mg/kg bw/day (nominal)
- Dose / conc.:
- 200 mg/kg bw/day (nominal)
- Dose / conc.:
- 100 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
Examinations
- Tissues and cell types examined:
- Bone Marrow
- Details of tissue and slide preparation:
- Immediately following termination, both femurs were dissected from each animal and bone marrow smears prepared following centrifugation and re-suspension. The smears were air-dried, fixed in absolute methanol, stained, allowed to air-dry and a cover slip applied using mounting medium.
- Evaluation criteria:
- Comparison was made between the number of micronucleated polychromatic erythrocytes occurring in each of the test item groups and the number occurring in the vehicle control group.
A positive mutagenic response is demonstrated when a statistically significant, dose-responsive, toxicologically relevant increase in the number of micronucleated polychromatic erythrocytes is observed for either the 24 or 48-hour kill times when compared to the vehicle control group.
If these criteria were not fulfilled, then the test item was considered to be non-genotoxic under the conditions of the test.
A positive response for bone marrow toxicity was demonstrated when the dose group mean polychromatic to normochromatic ratio was shown to be statistically significantly lower than the vehicle control group. - Statistics:
- The data was analysed following a transformation using Student's t-test (two tailed) and any significant results were confirmed using the one way analysis of variance.
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- See Table 1.
Any other information on results incl. tables
Table 1 Micronucleus Test–Summary of Group Mean Data
Treatment Group | Number of PCE with Micronuclei per 4000 PCE | PCE/NCE Ratio | ||
Group Mean | SD | Group Mean | SD | |
Vehicle Control 10 ml/kg 48-hour Sampling Time |
5.0 | 3.2 | 2.31 | 0.81 |
Positive Control 25 mg/kg 24-hour Sampling Time |
61.0*** | 16.9 | 1.78 | 1.27 |
2-Ethylanthraquinone (CAS No. 84-51-5) 400 mg/kg 48-hour Sampling Time |
2.4 | 2.5 | 1.25* | 0.23 |
2-Ethylanthraquinone (CAS No. 84-51-5) 200 mg/kg 48-hour Sampling Time |
4.8 | 1.6 | 1.02** | 0.20 |
2-Ethylanthraquinone (CAS No. 84-51-5) 100 mg/kg 48-hour Sampling Time |
4.8 | 1.3 | 1.53 | 0.45 |
PCE |
= |
Polychromaticerythrocytes |
NCE |
= |
Normochromaticerythrocytes |
SD |
= |
Standard deviation |
* |
= |
P<0.05 |
** |
= |
P<0.01 |
*** |
= |
P<0.001 |
Applicant's summary and conclusion
- Conclusions:
- The test item was considered to be non-genotoxic under the conditions of the test.
- Executive summary:
The ability of the test item to produce damage to chromosomes or aneuploidy when administered to rats was performed according to OECD TG 474.
The micronucleus test was performed with only male rats using the oral route. Groups of five rats were treated at the maximum tolerated dose of 400 mg/kg, with 200 and 100 mg/kg as the two lower dose levels and using arachis oil as the vehicle. Animals were dosed twice at time 0 and 24 hours. Bone marrow was extracted and smear preparations were made and stained. Polychromatic (PCE) and normochromatic (NCE) erythrocytes were scored for the presence of micronuclei and PCE/NCE ratio was calculated as an indicator for toxicity.
There was no evidence of any significant increases in the incidence of micronucleated polychromatic erythrocytes in animals dosed with the test item when compared to the vehicle control group and the test item was considered to be non-genotoxic under the conditions of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.